BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18373661)

  • 1. Cardiac resynchronization therapy and proarrhythmia: weathering the storm.
    Albert CM
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):716-9. PubMed ID: 18373661
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome.
    Nayak HM; Verdino RJ; Russo AM; Gerstenfeld EP; Hsia HH; Lin D; Dixit S; Cooper JM; Callans DJ; Marchlinski FE
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):708-15. PubMed ID: 18363690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency.
    Adelstein EC; Shalaby A; Saba S
    Pacing Clin Electrophysiol; 2010 Jul; 33(7):850-9. PubMed ID: 20202138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy.
    Kass DA
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S35-41. PubMed ID: 16138884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bifocal right ventricular pacing a viable form of cardiac resynchronization?
    Barold SS; Audoglio R; Ravazzi PA; Diotallevi P
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):789-94. PubMed ID: 18684274
    [No Abstract]   [Full Text] [Related]  

  • 6. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.
    Mangiavacchi M; Gasparini M; Genovese S; Pini D; Klersy C; Bragato R; Andreuzzi B; Municinò A; Regoli F; Galimberti P; Ceriotti C; Gronda E
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1425-32. PubMed ID: 18950300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamics and prognosis after primary cardiac resynchronization system implantation compared to "upgrade" procedures.
    Nägele H; Dodeck J; Behrens S; Azizi M; Hashagen S; Eisermann C; Castel MA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1265-71. PubMed ID: 18811806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRT begets CRT-D: is one better than the other?
    Lam SK; Tse HF; Lau CP
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1266-9. PubMed ID: 19017353
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable cardioverter defibrillators in children:
    Frias PA
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):77-8. PubMed ID: 15028077
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.
    Shalaby A; El-Saed A; Voigt A; Albany C; Saba S
    Pacing Clin Electrophysiol; 2008 May; 31(5):575-9. PubMed ID: 18439171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy.
    Kronborg MB; Albertsen AE; Nielsen JC; Mortensen PT
    Europace; 2009 Sep; 11(9):1177-82. PubMed ID: 19661114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cardiac resynchronization therapy on the incidence of electrical storm.
    Nordbeck P; Seidl B; Fey B; Bauer WR; Ritter O
    Int J Cardiol; 2010 Sep; 143(3):330-6. PubMed ID: 19359057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors.
    Bai R; Di Biase L; Elayi C; Ching CK; Barrett C; Philipps K; Lim P; Patel D; Callahan T; Martin DO; Arruda M; Schweikert RA; Saliba WI; Wilkoff B; Natale A
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1259-65. PubMed ID: 18631272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of ventricular arrhythmias: a therapeutic opportunity or strictly a marker of poor prognosis?
    Curtis AB
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1307-9. PubMed ID: 17034407
    [No Abstract]   [Full Text] [Related]  

  • 18. Rate-responsive pacing in patients with heart failure: long-term results of a randomized study.
    Nägele H; Rödiger W; Castel MA
    Europace; 2008 Oct; 10(10):1182-8. PubMed ID: 18723519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy.
    Sredniawa B; Lenarczyk R; Kowalski O; Pruszkowska-Skrzep P; Kowalczyk J; Musialik-Lydka A; Cebula S; Kalarus Z
    Europace; 2009 Jan; 11(1):106-14. PubMed ID: 19008239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP; Winters SL; Subacius H; Berger RD; Ellenbogen KA; Taylor SG; Schaechter A; Howard A; Kadish A;
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):755-61. PubMed ID: 19545338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.